Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6
| Autor: | Brett Hughes, Jean-Jacques Grob, Samantha Bowyer, Fiona Day, Rahul Ladwa, Brian Stein, Eva Muñoz-Couselo, Nicole Basset-Seguin, Alexander Guminski, Laurent Mortier, Axel Hauschild, Michael Migden, Chrysalyne Schmults, Suk-Young Yoo, Jocelyn Booth, Frank Seebach, Israel Lowy, Matthew Fury, Danny Rischin |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | SKIN The Journal of Cutaneous Medicine. 7:s175 |
| ISSN: | 2574-1624 |
| DOI: | 10.25251/skin.7.supp.175 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|